Vimarsana
Biggest News Aggregation in the World

Page 4 - Eng Eong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eng Eong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eng Eong Today - Breaking & Trending Today

Getting second Covid-19 infection not more dangerous, say S'pore experts rebutting US study, Latest Singapore News - Vimarsana News

Getting second Covid-19 infection not more dangerous, say S'pore experts rebutting US study, Latest Singapore News

Singapore News - An American study suggesting that people who are infected with Covid-19 a second time are at higher risk of organ failure and death is questionable, with inherent limitations and overstated conclusions, say local experts. The retrospective study by the Washington University... Read more at www.tnp.sg

Innovative Dengue Vaccine Readies in Europe - Vimarsana News

Innovative Dengue Vaccine Readies in Europe

QDENGA TAK-003 is a tetravalent dengue vaccine

Takeda gets positive CHMP opinion recommending nod of Dengue Vaccine in EU, Dengue-endemic countries - Vimarsana News

Takeda gets positive CHMP opinion recommending nod of Dengue Vaccine in EU, Dengue-endemic countries

Japan: Takeda has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of Takeda's dengue vaccine candidate,...

Takeda Pharmaceutical Company Limited: Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries - Vimarsana News

Takeda Pharmaceutical Company Limited: Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries

TAK-003 Recommended for the Prevention of Dengue Disease Caused by Any Dengue Virus Serotype in Individuals Four Years of Age and Older in the EU and in Dengue-Endemic Countries Participating in

Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries - Vimarsana News

Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries

14.10.2022 - Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of Takeda’s dengue vaccine candidate, TAK-003, for the prevention of dengue ...